Article 20 May 2024 Keeping Track Of Your Data — What You Need To Know About FDA's Draft Guidance On Data Integrity For In Vivo Bioavailability And Bioequivalence Studies United States Healthcare
Article 09 May 2024 2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems United States Healthcare
Article 11 Apr 2024 Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective United States Healthcare
Article 16 Jan 2024 FDA: Major Policy Shift Authorizes Florida's Plan To Import Drugs From Canada Worldwide Healthcare
Article 04 Dec 2023 FDA Issues Tip Sheet To Shore-Up The Supply Chain For Infant Formula And Critical Food United States Healthcare
Article 22 Nov 2023 Revisiting FDA's Original Guidance On Orange Book Listability In Light Of Heightened FTC Scrutiny United States IP
Article 16 Nov 2023 A Look At FDA's Proposed Changes To Labeling For Biosimilars And Interchangeable Biosimilars United States Healthcare
Article 14 Aug 2023 Important New FDA Guidance On Postmarketing Approaches To Obtain Data On Under-Represented Populations In Clinical Trials United States Healthcare